Aspirin may block bowel tumour formation
Researchers have shed light on how taking aspirin can help to prevent bowel cancer. They found that the painkiller blocks a key process linked to tumour formation...
List view / Grid view
News
SCIEX OS 1.4 launches with next-generation algorithms and complete data processing compatibility across SCIEX mass spectrometry platforms
New software offers improved workflow efficiency with enhanced data management and the tools to support 21 CFR Part 11 compliance across the SCIEX mass spectrometry portfolio...
CEM introduces the future of molecular sample preparation
CEM Corporation, a leading supplier of sample preparation systems, is pleased to introduce the all new EDGETM extraction system for rapid sample preparation of GC/LC samples...
Bruker introduces scimaX™ MRMS for novel phenomics workflows, and further enhances the timsTOF™ Pro for PASEF Proteomics at ASMS
At the 66th ASMS Conference, Bruker announces innovative mass spectrometry products and workflows for breakthroughs in life-science research, in clinical research and large-cohort validations in phenomics and proteomics, in novel biopharma applications and in applied toxicology and forensics markets...
Blood test may identify pregnant women at risk of premature birth
New research has found biomarkers that accurately identified pregnant women who would go on to deliver babies up to two months prematurely...
Mechanotargeting may open the door to better cancer drug delivery
Bioengineers may be able to use the unique mechanical properties of diseased cells, such as metastatic cancer cells, to help improve delivery of drug treatments to the targeted cells...
Thermo Scientific and Evosep collaborate to develop and promote robust, high-throughput workflows for clinical proteomics
Today, at the 66th Conference on Mass Spectrometry and Allied Topics, Thermo Scientific and Evosep announced a joint effort to develop and promote robust, high-throughput workflows for clinical proteomics...
OPTEL to showcase an entirely serialised line for the first time in Europe at Achema 2018
OPTEL GROUP, a leading global provider of traceability systems for diverse industries, namely for pharmaceuticals, medical devices, healthcare, food and natural resources, announced today that it will be exhibiting an entirely serialised line at this year’s edition of Achema, from 11 - 15 June 2018, in Frankfurt, Germany, at Stand F31…
EMA recommends marketing authorisation to Tegsedi for hereditary transthyretin amyloidosis
The EMA has recommended granting a marketing authorisation for Tegsedi, a medicine for the treatment of stage 1 or stage 2 polyneuropathy...
Treating Obstructive Sleep Apnea using cannabinoid-based drugs
Therapix Biosciences Ltd, have announced that the first subject was enrolled for its Phase IIa, a sponsor-initiated clinical trial for Obstructive Sleep Apnea...
DNA test may detect liver cancer
A group of researchers have completed a phase II study comparing a set of DNA markers to alpha-fetoprotein as a method to test for liver cancer....
Metformin found to be safe for most diabetics with kidney disease
Acidosis related to use of metformin seen only in those with severely decreased kidney function...
Immunotherapy using tumour infiltrating lymphocytes for metastatic cancer
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in a patient who was unresponsive to all other treatments.
ImmunoPET imaging noninvasively pinpoints colitis inflammation
A novel PET imaging method shows promise for noninvasively pinpointing sites of inflammation in people with inflammatory bowel disease...
FDA approves first biosimilar to Neulasta
The U.S. Food and Drug Administration has approved Fulphila (pegfilgrastim-jmdb) as the first biosimilar to Neulasta to help reduce the risk of infection during cancer treatment.
